drug regulation

Medicine regulation is a matter of life and death, and key to UK industries and science. Even Brexiters accept disadvantages of leaving EU.

21 countries have placed bids for the EU’s medicines and banking regulators. The winners’ gain will be another Brexit loss for Britain.

Call from ministers to cooperate with EU on medicines points to possibilities for similar compromises on regulation, trade, even migration.

If hardliners persuade PM to promise bonfire of red tape, we’ll struggle to get trade deal with EU and gain few countervailing benefits.

During the referendum Brexiters scaremongered relentlessly over Turkey, superstates, cancer and more. Their predictions have proven fiction.

Press claims EU red tape keeps cancer-fighting drug from patients. Manufacturer delays and UK’s value for money concerns are bigger hurdles.